Why Does hEDS Cause Stomach and GI Issues?
Published: | Updated:
Gastrointestinal issues in hEDS are caused by overly stretchy connective tissue in the digestive tract, combined with autonomic nervous system dysfunction (like POTS) and immune responses (like MCAS). This combination disrupts normal gut movement, leading to pain, bloating, and dysmotility.
Key Takeaways
- • Stretchy connective tissue in hEDS prevents the digestive tract from efficiently moving food, leading to dysmotility and gastroparesis.
- • Autonomic dysfunction, specifically POTS, is a major driver of gut symptoms because it disrupts the nerves that control digestion.
- • Mast Cell Activation Syndrome (MCAS) often co-occurs with hEDS and triggers painful gut inflammation and severe food sensitivities.
- • Management requires a careful balance of diet modifications, GI-safe medications, and treating underlying comorbidities like POTS and MCAS.
If you have hypermobile Ehlers-Danlos Syndrome (hEDS), you may frequently experience stomach pain and digestive distress. This happens because the connective tissue that makes up your digestive tract is too lax (stretchy). This laxity, combined with nervous system and immune system irregularities commonly seen in hEDS, makes it difficult for your gut to coordinate the muscle contractions needed to move food through your body properly [1][2]. This leads to dysmotility, a condition where food moves either too slowly or too quickly through your system, resulting in pain, bloating, nausea, and unpredictable bowel habits [3][4].
The Underlying Mechanics: Why hEDS Affects Your Gut
Digestive issues in hEDS are rarely caused by just one factor. They usually stem from a combination of three interconnected problems:
- Structural Laxity: Your entire gastrointestinal (GI) tract is made of connective tissue. In hEDS, this tissue is extra stretchy [1]. This can cause the valves (sphincters) between organs to stay partially open when they should close, or allow the stomach and intestines to stretch excessively under the weight of food [1]. In some cases, organs can sit lower in the abdomen or sag downward, a condition known as visceroptosis [1]. While this sounds intimidating, it is a recognized aspect of hypermobility that can often be supported with management strategies like abdominal binders.
- Autonomic Dysfunction: Digestion is controlled by the autonomic nervous system—the same system that regulates your heart rate and blood pressure [4]. Patients with hEDS frequently have Postural Orthostatic Tachycardia Syndrome (POTS) or other forms of dysautonomia [2][5]. When the autonomic nervous system misfires, the gut loses its rhythm, leading to severe dysmotility [2][6]. POTS is recognized as a major independent predictor of GI issues in hEDS patients [2].
- Mast Cell Activation: Many people with hEDS also have Mast Cell Activation Syndrome (MCAS) [7][8]. Mast cells are immune cells that release histamine and other inflammatory chemicals [6]. When these cells become overly reactive in the gut, they cause inflammation, pain, and food sensitivities [7][8]. The combination of hEDS, POTS, and MCAS is often referred to as the “trifecta,” and it significantly complicates digestive health [6][9].
Common GI Conditions in hEDS
The underlying mechanics of hEDS often lead to several distinct, yet overlapping, gastrointestinal diagnoses:
- Gastroparesis (Delayed Gastric Emptying): The stomach takes too long to empty its contents into the small intestine [3][2]. This causes early fullness (feeling stuffed after a few bites), severe nausea, vomiting, and upper abdominal pain [3].
- Gastroesophageal Reflux Disease (GERD): The stretchy valve between the esophagus and the stomach fails to close tightly, allowing stomach acid to splash upward [4][10]. This causes chronic heartburn, chest pain, and sometimes difficulty swallowing [4].
- Functional Dyspepsia and DGBIs: Patients frequently experience Disorders of Gut-Brain Interaction (DGBI), such as functional dyspepsia and Irritable Bowel Syndrome (IBS) [10][11]. These cause chronic pain, bloating, and irregular bowel habits (alternating diarrhea and constipation) because the nerves in the gut are hypersensitive to normal digestion [11][12].
- Severe Constipation and Pelvic Floor Dysfunction: Due to slow motility and a stretchy colon, stool can remain in the intestines for too long [13][4]. Additionally, stretchy connective tissue often leads to uncoordinated pelvic floor muscles (pelvic floor dyssynergia), making it physically difficult to have a bowel movement even when you need to [4].
- Vascular Compressions: Due to tissue laxity, blood vessels can compress nerves or other vessels in the abdomen. Known examples in the hEDS community include Median Arcuate Ligament Syndrome (MALS) and Superior Mesenteric Artery Syndrome (SMAS), which can cause severe pain after eating or limit how much food you can tolerate [14][15].
Management Strategies
Managing GI symptoms in hEDS requires a multidisciplinary approach that addresses both the digestive tract and your systemic symptoms [16][6]. Standard management strategies include:
- Dietary and Hydration Adjustments: Eating smaller, more frequent meals can ease the burden on a slow-emptying stomach [3][17]. For those struggling to get enough fluids for POTS due to early fullness, utilizing liquid calories or sipping specialized electrolyte solutions throughout the day can help [18]. Extreme restrictive diets (like very strict low-histamine diets) should be managed carefully with a dietitian to prevent malnutrition [19][20]. In severe cases where oral intake is not enough, doctors may discuss IV hydration or nutrition support [18].
- Navigating Medications:
- Prokinetics: These are prescription medications designed to stimulate the muscles of the digestive tract [18]. While effective, there is no “one-size-fits-all” prokinetic for hEDS, and several carry risks of side effects (like heart rhythm changes). It is important to discuss the safety profile of these drugs with your doctor [18][6].
- Laxatives: For unpredictable bowel habits, doctors often recommend gentler osmotic laxatives (which draw water into the bowel) over harsh stimulant laxatives, which can cause painful cramping in a sensitive gut [13].
- Pain Management: Finding GI-safe pain relief is a common challenge. Standard NSAIDs (like ibuprofen) can damage the stomach lining, and opioid medications notoriously slow down the gut, severely worsening dysmotility and constipation [13]. Always discuss the motility side effects of any pain medication with your care team.
- Non-Medication Therapies: Many patients benefit from specialized physical therapy for pelvic floor dysfunction, abdominal binders to provide external support for tissue laxity and POTS, or vagus nerve stimulation techniques to help calm the autonomic nervous system [4][5].
- Balancing Comorbidities: Treating your POTS and MCAS is often the most effective way to improve your gut function [6][21]. This requires close collaboration with your care team to ensure treatments for one condition don’t severely flare another [18][5].
When to Seek Urgent Care
Because dysmotility and severe constipation can occasionally escalate into medical emergencies, it is important to know your red flags. Seek immediate medical attention if you experience:
- Inability to keep any liquids down for more than 24 hours (risk of severe dehydration)
- Sudden, severe, and unrelenting abdominal pain
- Vomiting blood or material that looks like coffee grounds
- Inability to pass gas or have a bowel movement for an extended period accompanied by severe pain and a distended (hard, swollen) abdomen, which could indicate a bowel obstruction
Frequently Asked Questions
Why does hEDS cause delayed stomach emptying and dysmotility?
Can POTS affect my digestion?
How does MCAS contribute to hEDS gut issues?
What are safe pain medications for hEDS stomach pain?
How is severe constipation managed in hEDS?
Questions for Your Doctor
- • Given my combination of hEDS and GI symptoms, would a gastric emptying study or testing for vascular compressions (like MALS or SMAS) be appropriate for me?
- • What specific prokinetic options or bowel regimens are safest for my gut, keeping in mind the potential side effects on my heart and autonomic system?
- • Are there GI-safe pain management options I can use that won't worsen my dysmotility or constipation?
- • Can you refer me to a physical therapist who specializes in hypermobility and pelvic floor dysfunction?
- • Should we consult a neurogastroenterologist or an autonomic specialist to help coordinate my care for both POTS and dysmotility?
Questions for You
- • Do my digestive symptoms (pain, bloating, nausea) tend to worsen when I am upright and improve when I lie down, indicating a potential link to POTS?
- • How do I currently balance my need for fluids and salt with my stomach's limited capacity, and where am I falling short?
- • Have I noticed any specific triggers—such as certain foods, large meal sizes, or times of day—that make my dysmotility significantly worse?
- • How often am I relying on pain medications that might be unknowingly slowing down my gut?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Visceroptosis and the Ehlers-Danlos Syndrome.
Kucera S, Sullivan SN
Cureus 2017; (9(11)):e1828 doi:10.7759/cureus.1828.
PMID: 29375940 - 2
Prevalence and Predictors of Gastrointestinal Dysmotility in Patients with Hypermobile Ehlers-Danlos Syndrome: A Tertiary Care Center Experience.
Alomari M, Hitawala A, Chadalavada P, et al.
Cureus 2020; (12(4)):e7881 doi:10.7759/cureus.7881.
PMID: 32489735 - 3
Analysis of Antroduodenal Motility in Patients With Hypermobility Spectrum Disorders/Hypermobile Ehlers-Danlos Syndrome.
Sweerts KWE, Mujagic Z, Keszthelyi D, Conchillo JM
Alimentary pharmacology & therapeutics 2025; (61(4)):702-705 doi:10.1111/apt.18471.
PMID: 39745483 - 4
The association between Ehlers-Danlos syndrome-hypermobility type and gastrointestinal symptoms in university students: a cross-sectional study.
Fikree A, Aktar R, Morris JK, et al.
Neurogastroenterology and motility 2017; (29(3)) doi:10.1111/nmo.12942.
PMID: 27683076 - 5
Mechanisms underlying reflux symptoms and dysphagia in patients with joint hypermobility syndrome, with and without postural tachycardia syndrome.
Fikree A, Aziz Q, Sifrim D
Neurogastroenterology and motility 2017; (29(6)) doi:10.1111/nmo.13029.
PMID: 28191707 - 6
AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.
Aziz Q, Harris LA, Goodman BP, et al.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2025; (23(8)):1291-1302 doi:10.1016/j.cgh.2025.02.015.
PMID: 40387691 - 7
Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
Brock I, Prendergast W, Maitland A
American journal of medical genetics. Part C, Seminars in medical genetics 2021; (187(4)):473-481 doi:10.1002/ajmg.c.31940.
PMID: 34747107 - 8
Idiopathic osteoporosis, Ehlers-Danlos syndrome, postural orthostatic tachycardia syndrome, and mast cell activation disorder in a 27-year-old male patient: A unique case presentation.
Rattray C
Clinical case reports 2022; (10(5)):e05887 doi:10.1002/ccr3.5887.
PMID: 35600027 - 9
Comorbidities and neurosurgical interventions in a cohort with connective tissue disorders.
Ruhoy IS, Bolognese PA, Rosenblum JS, et al.
Frontiers in neurology 2024; (15()):1484504 doi:10.3389/fneur.2024.1484504.
PMID: 39931100 - 10
Gastrointestinal Symptoms in Marfan Syndrome and Hypermobile Ehlers-Danlos Syndrome.
Inayet N, Hayat JO, Kaul A, et al.
Gastroenterology research and practice 2018; (2018()):4854701 doi:10.1155/2018/4854701.
PMID: 30151001 - 11
A machine learning approach to stratify patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders according to disorders of gut brain interaction, comorbidities and quality of life.
Choudhary A, Fikree A, Ruffle JK, et al.
Neurogastroenterology and motility 2025; (37(1)):e14957 doi:10.1111/nmo.14957.
PMID: 39543811 - 12
Gastrointestinal disorders in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type: A review for the gastroenterologist.
Beckers AB, Keszthelyi D, Fikree A, et al.
Neurogastroenterology and motility 2017; (29(8)) doi:10.1111/nmo.13013.
PMID: 28086259 - 13
Rectal hyposensitivity: a common pathophysiological finding in patients with constipation and associated hypermobile Ehlers-Danlos syndrome.
Choudhary A, Vollebregt PF, Aziz Q, et al.
Alimentary pharmacology & therapeutics 2022; (56(5)):802-813 doi:10.1111/apt.17104.
PMID: 35758859 - 14
Abdominal Compression Syndromes in the Hypermobile Ehlers-Danlos Syndrome.
Milunsky A, Milunsky JM, Hsu R
American journal of medical genetics. Part A 2025; (197(12)):e64182 doi:10.1002/ajmg.a.64182.
PMID: 40653826 - 15
Exploring the Association Between Median Arcuate Ligament Syndrome and Hypermobile Ehlers-Danlos Syndrome: A Case Report.
Sorenson KR, Buckway T, Hall B
Cureus 2025; (17(8)):e90988 doi:10.7759/cureus.90988.
PMID: 41018362 - 16
Nutritional Implications of Patients with Dysautonomia and Hypermobility Syndromes.
Do T, Diamond S, Green C, Warren M
Current nutrition reports 2021; (10(4)):324-333 doi:10.1007/s13668-021-00373-1.
PMID: 34510391 - 17
Nutrient intake, dietary patterns and relationship to symptoms and comorbidities in hypermobile Ehlers-Danlos syndrome.
Topan R, Pandya S, Chance P, et al.
Clinical nutrition (Edinburgh, Scotland) 2025; (56()):106538 doi:10.1016/j.clnu.2025.11.022.
PMID: 41483485 - 18
Mechanisms and management of gastrointestinal symptoms in postural orthostatic tachycardia syndrome.
Tu Y, Abell TL, Raj SR, Mar PL
Neurogastroenterology and motility 2020; (32(12)):e14031 doi:10.1111/nmo.14031.
PMID: 33140561 - 19
The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS).
Kucharik AH, Chang C
Clinical reviews in allergy & immunology 2020; (58(3)):273-297 doi:10.1007/s12016-019-08755-8.
PMID: 31267471 - 20
Mast cell disorders in Ehlers-Danlos syndrome.
Seneviratne SL, Maitland A, Afrin L
American journal of medical genetics. Part C, Seminars in medical genetics 2017; (175(1)):226-236 doi:10.1002/ajmg.c.31555.
PMID: 28261938 - 21
Management of childbearing with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A scoping review and expert co-creation of evidence-based clinical guidelines.
Pezaro S, Brock I, Buckley M, et al.
PloS one 2024; (19(5)):e0302401 doi:10.1371/journal.pone.0302401.
PMID: 38748660
This page explains gastrointestinal complications of hEDS for educational purposes only. Always consult your gastroenterologist or care team before changing your diet, fluid intake, or medication regimen.
Stay up to date
Get notified when new research about Hypermobile Ehlers-Danlos Syndrome (hEDS) is published.
No spam. Unsubscribe anytime.